Merck Completes Acquisition of Acceleron Pharma Inc.
Merck known as MSD outside the United States and Canada, today announced the successful completion of the acquisition of Acceleron Pharma Inc. . “This is an important and strategic opportunity for our company to continue growing our cardiovascular portfolio and pipeline, that builds on our long and proud legacy in cardiovascular disease and further bolsters our business development strategy,” said Rob Davis, ...